Irmak Ferah Okkay

11PUBLICATIONS
18CO-AUTHORS
Major global burdens of diseasePharmacogenomicsBiomolecular modelling and designToxicology (incl. clinical toxicology)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 11, 2026
Pycnogenol attenuates thioacetamide-induced neurobehavioral impairment and hepatotoxicity via multi-target molecular modulation.

|Apr 17, 2026
Dapagliflozin ameliorates motor deficits in a Parkinson's disease model induced by 6-OHDA: An integrative in vivo and in silico approach from α-synuclein/A2AAR/TH/TNF-α to APAF-1/caspase-3 modulation.

|Apr 14, 2026
In silico and in vitro insights into the wound-healing potential of syringic acid: protective and regenerative effects on human fibroblasts.

Ufuk Okkay, İlkin Kazimov, Irmak Ferah Okkay

|Mar 06, 2026
Targeting AT1 receptors with telmisartan protects SH-SY5Y cells from 6-OHDA induced Parkinsonian neurotoxicity.

Omer Lutfi Gundogdu, Feyza Burul, Elif Tugce Akyol

|Jan 02, 2025
In Vivo Evidence for the Preventive Role of Vaccinium macrocarpon Aiton in Indomethacin-Induced Gastric Ulcer: Focusing on Antioxidant, Anti-Inflammatory and Anti-Apoptotic Mechanisms.

Ismail Cagri Aydin, Irmak Ferah Okkay, Ufuk Okkay

|May 21, 2024
Arbutin abrogates cisplatin-induced hepatotoxicity via upregulating Nrf2/HO-1 and suppressing genotoxicity, NF-κB/iNOS/TNF-α and caspase-3/Bax/Bcl2 signaling pathways in rats.

Irmak Ferah Okkay, Ademola Famurewa, Cemil Bayram

Pageof 2

Frequent Collaborators

3 joint publications

Selma Sezen

3 joint publications

Cemil Bayram

2 joint publications

Mustafa Özkaraca

2 joint publications

Ahmet Hacımüftüoğlu